A new nonaddictive pain relief method for musculoskeletal disorders
Official title: Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain
Funded at University of Nebraska Medical Center · NIH-10881885 · Data updated 2026-11-12
This study is testing a new way to relieve pain for people with muscle and joint issues by using a special gel that releases a safe, non-addictive medication right where it hurts, helping to manage pain without the risks of traditional opioids.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project start | September 7, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $464,079 |
| NIH project number | 5R01AR080500-03 |
| Project ID | NIH-10881885 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from acute or chronic musculoskeletal pain, particularly those who may be at risk for opioid dependency.
✕Less likely to help
Patients who do not experience musculoskeletal pain or have contraindications to opioid use may not benefit from this research.
What this research studies
This research focuses on developing a novel pain relief method for musculoskeletal disorders using a nonaddictive opioid prodrug. The approach involves creating a thermoresponsive hydrogel that releases the prodrug locally at the site of pain, providing sustained relief without affecting the spinal cord or brain. This method aims to minimize the risks associated with traditional opioids, such as addiction and dependency, while still delivering effective pain management. Patients will receive localized treatment that avoids systemic exposure, enhancing safety and efficacy.
Why it matters
Potential benefit: If successful, this research could provide a safer alternative to traditional opioids for managing musculoskeletal pain.
How similar studies have gone: Other research has shown promise in developing nonaddictive pain relief methods, but this specific approach using a thermoresponsive prodrug is relatively novel.
Where this research is happening
-
University of Nebraska Medical Center
Omaha, United States Active
Researchers
- Principal investigator: Wang, Dong — University of Nebraska Medical Center
- Study coordinator: Wang, Dong
Related research
Other NIH-funded projects on the same topics.
-
mHealth tool to boost physical therapy outcomes for adults with musculoskeletal pain
A mobile health app is being tested to help adults in physical therapy stay on track with home exercises and improve pain and function.
-
Biopsychosocial factors in pediatric chronic musculoskeletal pain
A study at Cincinnati Children’s Hospital will look at how biological, psychological, and social factors contribute to chronic muscle and joint pain in young people to find better ways to help them.
-
Nonaddictive pain-relief prodrug gel for joint and musculoskeletal pain
A new, nonaddictive pain-relief gel uses a hydromorphone prodrug that stays at the site of pain to reduce pain without strong addiction risk.
-
Neurobiological and psychosocial factors that may turn acute teen pain into chronic pain
A study following teenagers with acute musculoskeletal pain to understand why some develop chronic pain and how biology and psychology interact to shape their outcomes.
-
Tech-guided walking plus Tai Chi to improve function for veterans with COPD and chronic pain
This program helps veterans with COPD and long-term muscle or joint pain use a web-based step program together with Tai Chi to move more and feel stronger.
-
Resilience Coaching for Teens with Long-Lasting Muscle and Bone Pain
This project offers resilience coaching to help teenagers manage ongoing muscle and bone pain and improve their well-being.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.